PLOD2 and gastric cancer: PLOD family members (PLOD1, PLOD2, and PLOD3) were shown to be associated with poor prognosis and could act as potential biomarkers or therapeutic targets for both gastric cancer and hepatocellular carcinoma [18,20,22].